Pregnancy-associated mortality due to cardiovascular disease: Impact of hypertensive disorders of pregnancy
- PMID: 38375930
- PMCID: PMC10978238
- DOI: 10.1111/ppe.13055
Pregnancy-associated mortality due to cardiovascular disease: Impact of hypertensive disorders of pregnancy
Abstract
Background: Reported rates of maternal mortality in the United States have been staggeringly high and increasing, and cardiovascular disease (CVD) is a chief contributor to such deaths. However, the impact of hypertensive disorders of pregnancy (HDP) on the short-term risk of cardiovascular death is not well understood.
Objectives: To evaluate the association between HDP (chronic hypertension, gestational hypertension, preeclampsia, eclampsia, and superimposed preeclampsia) and pregnancy-associated mortality rates (PMR) from all causes, CVD-related causes both at delivery and within 1 year following delivery.
Methods: We used the Nationwide Readmissions Database (2010-2018) to examine PMRs for females 15-54 years old. International Classification of Disease 9 and 10 diagnosis codes were used to identify pregnancy-associated deaths due to HDP and CVD. Discrete-time Cox proportional hazards regression models were used to calculate adjusted hazard ratios (HR) and 95% confidence intervals (CI) for mortality at delivery (0 days) and at <30, <60, <90, <180, and <365 days after delivery in relation to HDP.
Results: Of 33,417,736 hospital deliveries, the rate of HDP was 11.0% (n = 3,688,967), and the PMR from CVD was 6.4 per 100,000 delivery hospitalisations (n = 2141). Compared with normotensive patients, HRs for CVD-related PMRs increased with HDP severity, reaching over 58-fold for eclampsia patients. HRs were higher for stroke-related (1.2 to 170.9) than heart disease (HD)-related (0.99 to 39.8) mortality across all HDPs. Except for gestational hypertension, the increased risks of CVD mortality were evident at delivery and persisted 1 year postpartum for all HDPs.
Conclusions: HDPs are strong risk factors for pregnancy-associated mortality due to CVD at delivery and within 1 year postpartum; the risks are stronger for stroke than HD-related PMR. While absolute PMRs are low, this study supports the importance of extending postpartum care beyond the traditional 42-day postpartum visit for people whose pregnancies are complicated by hypertension.
Keywords: cardiovascular disease; heart disease; hypertensive disorders of pregnancy; pregnancy‐associated mortality; stroke.
© 2024 The Authors. Paediatric and Perinatal Epidemiology published by John Wiley & Sons Ltd.
Figures




Similar articles
-
Maternal hypertensive disorder of pregnancy and offspring early-onset cardiovascular disease in childhood, adolescence, and young adulthood: A national population-based cohort study.PLoS Med. 2021 Sep 28;18(9):e1003805. doi: 10.1371/journal.pmed.1003805. eCollection 2021 Sep. PLoS Med. 2021. PMID: 34582464 Free PMC article.
-
Maternal Coronary Heart Disease, Stroke, and Mortality Within 1, 3, and 5 Years of Delivery Among Women With Hypertensive Disorders of Pregnancy and Pre-Pregnancy Hypertension.J Am Heart Assoc. 2021 Feb;10(5):e018155. doi: 10.1161/JAHA.120.018155. Epub 2021 Feb 23. J Am Heart Assoc. 2021. PMID: 33619981 Free PMC article.
-
Maternal hypertensive disorders during pregnancy and the risk of offspring diabetes mellitus in childhood, adolescence, and early adulthood: a nationwide population-based cohort study.BMC Med. 2023 Feb 16;21(1):59. doi: 10.1186/s12916-023-02762-5. BMC Med. 2023. PMID: 36797785 Free PMC article.
-
Incidence of postpartum hypertension within 2 years of a pregnancy complicated by pre-eclampsia: a systematic review and meta-analysis.BJOG. 2021 Feb;128(3):495-503. doi: 10.1111/1471-0528.16545. Epub 2020 Oct 21. BJOG. 2021. PMID: 32981216
-
Risk of future cardiovascular diseases in different years postpartum after hypertensive disorders of pregnancy: A systematic review and meta-analysis.Medicine (Baltimore). 2022 Jul 29;101(30):e29646. doi: 10.1097/MD.0000000000029646. Medicine (Baltimore). 2022. PMID: 35905265 Free PMC article.
Cited by
-
Peripartum dapagliflozin improves late-life maternal cardiovascular outcomes in a murine model of superimposed preeclampsia.Am J Obstet Gynecol. 2025 Mar 29:S0002-9378(25)00181-4. doi: 10.1016/j.ajog.2025.03.035. Online ahead of print. Am J Obstet Gynecol. 2025. PMID: 40164294
-
Global, regional, and national burden and trends of intracerebral hemorrhage among adolescents and young adults aged 15-39 years from 1990 to 2021: a comprehensive trend analysis based on the global burden of disease study 2021.Front Neurol. 2025 Apr 23;16:1538413. doi: 10.3389/fneur.2025.1538413. eCollection 2025. Front Neurol. 2025. PMID: 40337169 Free PMC article.
-
Obstetrical complications and chronic health along the life course: What we know, what we don't, and where we go from here?Paediatr Perinat Epidemiol. 2024 Mar;38(3):163-167. doi: 10.1111/ppe.13074. Paediatr Perinat Epidemiol. 2024. PMID: 38536736 Free PMC article. No abstract available.
-
Intact NOX2 in T Cells Mediates Pregnancy-Induced Renal Damage in Dahl SS Rats.Hypertension. 2024 Nov;81(11):2357-2367. doi: 10.1161/HYPERTENSIONAHA.124.23303. Epub 2024 Sep 20. Hypertension. 2024. PMID: 39301728
-
Current Evidence of Maternal Infection With Chlamydia trachomatis and Preeclampsia Risk.Am J Reprod Immunol. 2025 May;93(5):e70080. doi: 10.1111/aji.70080. Am J Reprod Immunol. 2025. PMID: 40298141 Review.
References
-
- Hoyert DL. Maternal mortality rates in the United States, 2021. NCHS Health E-Stats. 2023. doi: DOI: 10.15620/cdc:124678. - DOI
-
- Declercq E, Zephyrin L. Maternal Mortality in the United States: A Primer. 2020.
-
- Hoyert DL, Minino AM. Maternal Mortality in the United States: Changes in Coding, Publication, and Data Release, 2018. Natl Vital Stat Rep. 2020;69:1–18. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical